Difference between revisions of "Pal SK, et al. Eur. Urol. (2019) cited as Ref 622 in DOI: 10.1038/s41392-020-0110-5 (Q9885)"

@@ Property / First Author string @@
+Pal SK
@@ Property / First Author string: Pal SK / rank @@
+Normal rank
@@ Property / Second Author string @@
+Swami U
@@ Property / Second Author string: Swami U / rank @@
+Normal rank
@@ Property / Third Author string @@
+Agarwal N
@@ Property / Third Author string: Agarwal N / rank @@
+Normal rank
@@ Property / Publication Date @@
+Timestamp +2019-01-01T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 year
Before 0
After 0
-Timestamp
++2019-01-01T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+year
 Before
 After
@@ Property / Publication Date: 2019 / rank @@
+Normal rank
@@ Property / Published In Name String @@
+Eur. Urol.
@@ Property / Published In Name String: Eur. Urol. / rank @@
+Normal rank
@@ Property / title @@
+Characterizing the Wnt pathway in advanced prostate cancer: when why and how. (English)
+Normal rank
@@ links / sliswiki / name / links / sliswiki / name @@
+Pal SK, et al. Eur. Urol. (2019) cited as Ref 622 in DOI: 10.1038/s41392-020-0110-5

Latest revision as of 22:05, 20 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

Language	Label	Description	Also known as
English	Pal SK, et al. Eur. Urol. (2019) cited as Ref 622 in DOI: 10.1038/s41392-020-0110-5	Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8